99: Key Takeaways: Society of Benign Prostate Disease 2024 Annual Meeting - Kevin C. Zorn, MD, FRCSC, FACS

I was recently honored to be a guest speaker among the innovators, stakeholders, and pioneering minds in managing benign prostate hyperplasia at the annual assembly of the Society of Benign Prostate Disease, held in Dallas this February. 

Today, I am delighted to have one of the Society of Benign Prostate Disease board of directors, Dr. Kevin Zorn, joining me to share an insider perspective as we review the key takeaways from the meeting and bring you up to speed on the latest technologies for evaluating and managing BPH. We will also offer a sneak peek into several new advancements coming down the pipeline. 

Dr. Kevin Zorn, from the BPH Canada Clinic in Montreal, is a board-certified urologist and former Associate Professor of Urology at the Universities of Montreal and Chicago, sub-specializing in robotic surgery and BPH surgical care. Throughout his career, Dr. Zorn has been committed to research and innovation. He was the first in Canada and Quebec to use many new BPH technologies, including Greenlight XPS, Rezum, ITind, Optilume, and aquablation.

Dr. Zorn is a senior author of the BPH guidelines for the Canadian Urological Association, having authored 345 peer-reviewed publications and 12 book chapters on BPH and minimally invasive surgical care. He has lectured, taught, and practiced surgery globally and is intimately involved in developing several new pioneering BPH technologies.

Stay tuned for the latest insights and breakthroughs as we unveil the future of BPH management.

Disclaimer: The Prostate Health Podcast is for informational purposes only. Nothing in this podcast should be construed as medical advice. By listening to the podcast, no physician-patient relationship has been formed. For more information and counseling, you must contact your personal physician or urologist with questions about your unique situation.

.css-j9qmi7{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex-direction:row;-ms-flex-direction:row;flex-direction:row;font-weight:700;margin-bottom:1rem;margin-top:2.8rem;width:100%;-webkit-box-pack:start;-ms-flex-pack:start;-webkit-justify-content:start;justify-content:start;padding-left:5rem;}@media only screen and (max-width: 599px){.css-j9qmi7{padding-left:0;-webkit-box-pack:center;-ms-flex-pack:center;-webkit-justify-content:center;justify-content:center;}}.css-j9qmi7 svg{fill:#27292D;}.css-j9qmi7 .eagfbvw0{-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;color:#27292D;}